IMMUCELL CORP ICCC 48.35
Health Care · NASDAQ · Data as of 2026-08-13
IMMUCELL CORP (ICCC) has delivered +12.6% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #984 of 1968 stocks overall and #105 of 260 in the Health Care sector by Steady Score.
Industry
Diagnostic Substances
Steady Score
48.35
Overall Rank
#984 / 1968
Sector Rank
#105 / 260
Revenue CAGR
+12.6%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio